×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BROOKS LABORATORIES LTD. | 257.29 | 26.51 | 255.12 | 0.9 | 435.0 | 214.0 |
| EVEREST ORGANICS LTD. | NA | NA | NA | NA | 389 | 62.7 |
| ZIM Laboratories Limited | 729.03 | -16.92 | 714.28 | -0.35 | 366 | 39.0 |
BROOKS LABORATORIES LIMITED, with Security Code 533543, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.6 | 15.7 | 24.3 | 21.7 | 17.7 | 17.9 | 20.8 | 20.5 | 23.3 | 25.5 |
| Expenses | 12.7 | 15.7 | 22.6 | 20.7 | 17.3 | 17.7 | 19.3 | 18.9 | 21.7 | 22.4 |
| Operating Profit | -0.1 | 0.0 | 1.7 | 1.1 | 0.4 | 0.3 | 1.5 | 1.6 | 1.7 | 3.1 |
| OPM % | -0.94% | 0.16% | 7.06% | 5.04% | 2.14% | 1.57% | 7.26% | 7.68% | 7.15% | 12.26% |
| Other Income | 0.0 | 0.1 | 0.1 | 0.2 | 0.7 | 0.1 | 0.2 | 0.0 | 0.6 | 0.2 |
| Interest | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 |
| Depreciation | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Profit before tax | -0.7 | -0.5 | 1.2 | 0.6 | 0.3 | -0.2 | 1.0 | 0.9 | 1.6 | 2.7 |
| Tax % | 0% | 0% | 0% | -4.3% | 0% | 0% | 0% | 0% | -6.5% | 0% |
| Net Profit | -0.7 | -0.5 | 1.2 | 0.6 | 0.3 | -0.2 | 1.0 | 0.9 | 1.4 | 2.7 |
| EPS in Rs | -0.29 | -0.22 | 0.46 | 0.23 | 0.1 | -0.08 | 0.36 | 0.36 | 0 | 0.9 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.3 | 12.6 | 15.7 | 24.3 | 21.7 | 17.7 | 17.9 | 20.8 | 20.5 | 23.3 |
| Expenses | 23.9 | 16.3 | 19.6 | 25.4 | 25.1 | 17.3 | 19.9 | 24.2 | 22.0 | 24.5 |
| Operating Profit | -8.6 | -3.7 | -3.9 | -1.1 | -3.4 | 0.4 | -1.9 | -3.4 | -1.5 | -1.2 |
| OPM % | -55.9% | -29.32% | -24.92% | -4.53% | -15.45% | 2.14% | -10.71% | -16.4% | -7.28% | -5.27% |
| Other Income | 0.4 | 0.0 | 0.1 | 0.1 | 0.2 | 0.7 | 0.1 | 0.2 | 0.0 | 0.6 |
| Interest | 0.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 |
| Depreciation | 2.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 |
| Profit before tax | -11.5 | -4.3 | -4.5 | -1.6 | -3.9 | 0.3 | -2.4 | -4.0 | -2.1 | -1.3 |
| Tax % | -15.2% | 0% | 0% | 0% | -4.3% | 0% | 0% | 0% | 0% | -6.6% |
| Net Profit | -9.5 | -4.3 | -4.5 | -1.6 | -3.9 | -9.6 | -2.4 | -4.0 | -2.1 | -1.5 |
| EPS in Rs | -2.03 | -1.74 | -1.75 | -0.64 | -1.51 | -3.77 | -0.94 | -1.51 | -0.82 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 8% |
| 3 Years: | 1% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | 16% |
| 3 Years: | 28% |
| TTM: | 240% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 38% |
| 3 Years: | 15% |
| 1 Year: | 49% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 1% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 38% |
| 3 Years: | 15% |
| 1 Year: | 49% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|